DBT looks for pharma firms to commercialise cholera vaccine
Department of Biotechnology (DBT) has started scouting for industrial partner to licence and commercialise a live, oral cholera vaccine (IOCV) strain, with a view to make an affordable vaccine available in domestic and overseas markets.
